European Oncology and Haematology
SJR0.151
GB

Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.151 | Q4 | 16.7% | |
| 2024 | — | — | 0.150 | Q4 | 19.9% | |
| 2023 | — | — | 0.196 | Q4 | 34.4% | |
| 2022 | — | — | 0.120 | Q4 | 21.0% | |
| 2021 | — | — | 0.134 | Q4 | 27.1% | |
| 2020 | — | — | 0.116 | Q4 | 8.5% | |
| 2019 | — | — | 0.139 | Q4 | 25.0% | |
| 2018 | — | — | 0.136 | Q4 | 17.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2045-5283
ISSN
2045-5275
country
coverage
2012-2024